Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tani

Showing results (461-470 of 532) with videos related to

Pageof 54
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatinK Noguchi, H Tanimura, H Yamaue, et al.
Journal of Surgical Oncology|January 1, 1992
Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancerH Yamaue, H Tanimura, Y Aoki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Regulating factors of liver regeneration after hepatectomyM Tani, T Tomiya, S Yamada, et al.
Nihon Jinzo Gakkai Shi|February 1, 1994
[Effect of recombinant atrial natriuretic peptide (r-ANP) on ischemic and cyclosporine-induced kidney damage in rats]K Yoshida, Y Kagebayashi, T Saka, et al.
Oncology|July 28, 2001
Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a caseM Iwahashi, M Nakamori, M Tani, et al.
Anticancer Research|May 1, 1995
Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinomaM Iwahashi, H Tanimura, H Yamaue, et al.
Carcinogenesis|July 11, 1998
Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primersS Takenoshita, M Tani, A Mogi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1992
[Malignant mesodermal mixed tumor of the bladder: report of a case]H Azuma, H Ueda, M Tani, et al.
Anticancer Research|July 1, 1994
Ubenimex treatment enhances the susceptibility of gastric cancer cell lines to lymphokine-activated killer cellsM Iwahashi, H Tanimura, H Yamaue, et al.
Oncology Reports|May 19, 2011
Cisplatin modulates tumor cell susceptibility to tumor-infiltrating lymphocytes in vivoK Noguchi, H Tanimura, H Yamaue, et al.
Pageof 54

Showing results (461-470 of 532) with videos related to

Sort By:
Pageof 54
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatinK Noguchi, H Tanimura, H Yamaue, et al.
Journal of Surgical Oncology|January 1, 1992
Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancerH Yamaue, H Tanimura, Y Aoki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Regulating factors of liver regeneration after hepatectomyM Tani, T Tomiya, S Yamada, et al.
Nihon Jinzo Gakkai Shi|February 1, 1994
[Effect of recombinant atrial natriuretic peptide (r-ANP) on ischemic and cyclosporine-induced kidney damage in rats]K Yoshida, Y Kagebayashi, T Saka, et al.
Oncology|July 28, 2001
Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a caseM Iwahashi, M Nakamori, M Tani, et al.
Anticancer Research|May 1, 1995
Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinomaM Iwahashi, H Tanimura, H Yamaue, et al.
Carcinogenesis|July 11, 1998
Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primersS Takenoshita, M Tani, A Mogi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1992
[Malignant mesodermal mixed tumor of the bladder: report of a case]H Azuma, H Ueda, M Tani, et al.
Anticancer Research|July 1, 1994
Ubenimex treatment enhances the susceptibility of gastric cancer cell lines to lymphokine-activated killer cellsM Iwahashi, H Tanimura, H Yamaue, et al.
Oncology Reports|May 19, 2011
Cisplatin modulates tumor cell susceptibility to tumor-infiltrating lymphocytes in vivoK Noguchi, H Tanimura, H Yamaue, et al.
Pageof 54